Rare diseases
Investigational molecules
Locations
Back to Greece680 clinical trials in Efkarpia, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
GreeceStudy of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion
GreeceStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
GreeceStudy on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa
GreeceStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
GreeceStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
GreeceStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
GreeceStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
GreeceStudy on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases
GreeceStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
GreeceStudy of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)
GreeceStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
GreeceThe busiest research cities in the country
What the registry says about research in the country
Extensive trials focusing on hidradenitis suppurativa and atopic dermatitis, evaluating novel therapeutic approaches and treatment combinations to improve patient outcomes.
Multiple studies testing new biological therapies and their long-term safety profiles.
Research centered on lupus erythematosus and Sjögren's Disease, investigating targeted therapies to manage disease progression and symptoms.
Studies aim to evaluate new therapeutic agents for better disease control.
Innovative trials examining treatments for Type 2 Diabetes and obesity, with focus on cardiovascular outcomes and weight management.
Research comparing new therapeutic options against established treatments.
Advanced research in metastatic breast cancer and colorectal cancer, evaluating targeted therapies and combination treatments.
Focus on improving progression-free survival in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
